Woman and Man | Between 3 years et 18 years
- | Country :
- France
- | organs :
- Leucémies aiguës
- | Specialty :
- Thérapies Ciblées
- Pédiatrie
Extract
A phase I/II, open-label, dose-escalating study to evaluate the safety, tolerability and pharmacokinetics of twice daily oral midostaurin and to evaluate the preliminary clinical and pharmacodynamic response in pediatric patients with relapsed or refractory leukemia.
Scientific Abstract
en cours d'intégration;